Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $8.25 M | -58.78% |
2023 | $20.01 M | -0.11% |
2022 | $20.04 M | -1.1% |
2021 | $20.26 M | 349.97% |
2020 | $4.5 M | 59.31% |
2019 | $2.82 M | -70.73% |
2018 | $9.65 M | -47.22% |
2017 | $18.29 M | -22.64% |
2016 | $23.65 M | 42.25% |
2015 | $16.62 M | -76.7% |
2014 | $71.35 M | 987.87% |
2013 | $6.55 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.13 B | $0.59 B | ๐บ๐ธ USA |
Novartis NVS | $18.64 M | $83.53 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $10.32 M | $0.31 B | ๐บ๐ธ USA |
Eli Lilly LLY | $56.64 M | $0.12 B | ๐บ๐ธ USA |
Amgen AMGN | $52.25 M | $0.21 B | ๐บ๐ธ USA |
Sanofi SNY | $21.22 M | $52.23 M | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | ๐บ๐ธ USA |
Seagen
SGEN | N/A | $37.49 M | ๐บ๐ธ USA |